SCHEMBL19080001

SCHEMBL19080001

c1cc(-c2c3ccccc3c(-c3ccc4ccccc4c3)c3ccccc23)cc(-c2cc3ccccc3c3c2oc2cc4ccccc4cc23)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 5/20 0.43
MIF P14174 1/20 0.36
CYP1A1 P04798 2/20 0.36
CYP1A2 P05177 1/20 0.36
FYN P06241 1/20 0.36
MAPK3 P27361 1/20 0.36
AHR P35869 1/20 0.36
PAX8 Q06710 1/20 0.36
ABCG2 Q9UNQ0 1/20 0.36
ALOX5 P09917 3/20 0.35
PRKDC P78527 1/20 0.35
GSTP1 P09211 1/20 0.35
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
CYP1B1 Q16678 1/20 0.34
ESR1 P03372 2/20 0.34
ESR2 Q92731 2/20 0.34
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079935 0.94 ALOX5 (0.40) GPR84CYP1A1CYP1A2FYNMAPK3
SCHEMBL17589574 0.93 GPR84 (0.43) GPR84MIFCYP1A1CYP1A2FYN
SCHEMBL19080110 0.93 ALOX5 (0.36) GPR84CYP1A1CYP1A2FYNMAPK3
SCHEMBL17737576 0.93 GPR84 (0.42) GPR84MIFCYP1A1CYP1A2FYN
SCHEMBL10130461 0.91 GPR84 (0.44) GPR84MIFCYP1A1CYP1A2FYN
SCHEMBL17589551 0.91 GPR84 (0.43) GPR84MIFCYP1A1CYP1A2FYN
SCHEMBL17737541 0.90 GPR84 (0.45) GPR84MIFCYP1A1CYP1A2FYN
SCHEMBL17737539 0.90 ABCG2 (0.39) GPR84CYP1A1CYP1A2FYNMAPK3
SCHEMBL22952663 0.89 GPR84 (0.35) GPR84CYP1A1CYP1A2FYNMAPK3
SCHEMBL19079968 0.89 GPR84 (0.36) GPR84CYP1A1CYP1A2FYNMAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 GPR84 2425/4885MIF 2417/4885CYP1A1 147/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 GPR84 2425/4885MIF 2417/4885CYP1A1 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.